← FDA Drug Approvals (Drugs@FDA)
TREPROSTINIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2020-05-22
Drug application
- FDA Application #
ANDA210214- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TREPROSTINIL
- Generic name
- TREPROSTINIL
- Active ingredients
- TREPROSTINIL
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- DR REDDYS
- Manufacturer
- Dr.Reddy's Laboratories Inc.,
- First approval
- 2020-05-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown